Hansa Biopharma AB (publ)

Short Term Long Term Short Term Comparison Long Term Comparison
  • HNSA
  • 1d4.40%
  • 1w-3.49%
  • 1m3.26%
  • 1y-42.80%
ATH
  • ATH Price$348.00
  • ATH Date2018-10-03
  • % since ATH-91.26%
  • % to ATH1,044.74%
ATL
  • ATL Price$2.26
  • ATL Date2012-10-23
  • % from ATL1,246.26%
  • Last Low Price$21
  • Last Low Date2023-10-13
  • % From Last Low44.76%
IPO
  • IPO Price$14.00
  • % Current ROI USD217.14%
  • ATH Price$348.00
  • % ROI ATH 1,541,118.64%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="HNSA"]

Key Data [addtoany]

Current price $30.4
Sector Healthcare
Industry Biotechnology
Today's High/Low $32/$30.18
Volume 678,052.00
Previous Close $29.12
52 Week High/Low $58.1/$20.14
Market Cap 1,601,222,656.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $-9.78
Annualized Dividend $0
$30.4
[addtoany]
Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity